AdaptHealth Corp. Form 8-K Summary
Business Context and Reporting Period
AdaptHealth Corp. (AHCO) filed this Current Report on Form 8-K on April 10, 2026, to disclose the entry into a new material definitive credit agreement and the termination of its prior credit facility. The company is a Delaware corporation headquartered in Conshohocken, PA.
Key Financial Metrics and Capital Structure
The new Credit Agreement, dated April 10, 2026, establishes the following capital structure:
- Revolving Loan Commitments: $450.0 million (includes a $75.0 million letter of credit sublimit).
- Initial Term Loans: $325.0 million.
- Delayed Draw Term Loan Commitments: $325.0 million (available for up to two years post-closing).
- Interest Rates: Based on Base Rate or Term SOFR plus an Applicable Margin ranging from 0.125% to 1.000% (Base Rate) or 1.125% to 2.000% (SOFR), dependent on leverage ratios.
- Maturity: Scheduled for April 13, 2031, subject to a springing maturity date 91 days prior to the maturity of the 2028 Senior Notes if outstanding indebtedness exceeds $15.0 million.
The filing does not provide specific revenue, profit, cash flow, or current liquidity figures for the reporting period.
Material Changes Versus Prior Period
The company executed a refinancing transaction with the following material changes:
- Termination of Prior Debt: All outstanding indebtedness under the Prior Credit Agreement (dated January 20, 2021) was repaid in full using proceeds from the new Initial Term Loans.
- Refinancing Strategy: The Delayed Draw Term Loan facility is designated to potentially refinance $325.0 million of outstanding 6.125% Senior Notes due 2028.
- Covenant Structure: The new agreement introduces financial maintenance covenants requiring a Consolidated Total Leverage Ratio not to exceed 3.50 to 1.00 (4.00 to 1.00 during acquisition periods) and a Consolidated Interest Coverage Ratio of at least 3.00 to 1.00.
Outlook, Risks, and Management Commentary
Management indicated that borrowings under the revolving facility will be used for working capital, general corporate purposes, capital expenditures, and permitted acquisitions. The Credit Agreement includes customary events of default, including cross-defaults, bankruptcy, and specific compliance failures related to healthcare laws. The agreement restricts the company's ability to incur additional indebtedness, create liens, make investments, or pay dividends without meeting specific conditions.
Key Facts for Investor Verification
- Verify the exact amount of the 2028 Senior Notes currently outstanding and the timeline for potential refinancing using the delayed draw facility.
- Confirm the company's current Consolidated Total Leverage Ratio and Interest Coverage Ratio to ensure compliance with the new 3.50x and 3.00x covenants.
- Review the specific terms of the "springing maturity date" to understand the risk of accelerated repayment if the 2028 Senior Notes are not refinanced or retired.
- Assess the impact of the new interest rate margins (up to 2.000% over SOFR) on future interest expense compared to the prior credit agreement.